trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Fibrosis D005355 23 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Hypersensitivity D006967 22 associated lipids
Medulloblastoma D008527 22 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Translocation, Genetic D014178 20 associated lipids
Leishmaniasis D007896 19 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Carcinoma D002277 18 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Brain Neoplasms D001932 15 associated lipids
Radiation Injuries D011832 14 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Neoplasms D009369 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Cat Diseases D002371 12 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Retinoblastoma D012175 12 associated lipids
Keloid D007627 12 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Enteritis D004751 8 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Genomic Instability D042822 7 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Leukemia, Myelomonocytic, Acute D015479 6 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Opioid-Related Disorders D009293 5 associated lipids
Osteomalacia D010018 5 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Spinocerebellar Ataxias D020754 4 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Neuroendocrine Tumors D018358 4 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Meester-Smoor MA et al. The ETS family member TEL binds to nuclear receptors RAR and RXR and represses gene activation. 2011 PLoS ONE pmid:21949683
Chan N et al. Attenuation of choroidal neovascularization by histone deacetylase inhibitor. 2015 PLoS ONE pmid:25807249
Ying H et al. Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB. 2012 PLoS ONE pmid:23166597
Vire B et al. Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions. 2009 PLoS ONE pmid:19759901
Cui Y et al. Interference of the Histone Deacetylase Inhibits Pollen Germination and Pollen Tube Growth in Picea wilsonii Mast. 2015 PLoS ONE pmid:26710276
Schor IE et al. Perturbation of chromatin structure globally affects localization and recruitment of splicing factors. 2012 PLoS ONE pmid:23152763
Charni Chaabane S et al. PDGF-D expression is down-regulated by TGFβ in fibroblasts. 2014 PLoS ONE pmid:25280005
Yang DH et al. Dynamic rearrangement of F-actin is required to maintain the antitumor effect of trichostatin A. 2014 PLoS ONE pmid:24846135
Gan L et al. Histone deacetylases regulate gonadotropin-releasing hormone I gene expression via modulating Otx2-driven transcriptional activity. 2012 PLoS ONE pmid:22761896
Kawasaki H et al. Mouse embryonic stem cells inhibit murine cytomegalovirus infection through a multi-step process. 2011 PLoS ONE pmid:21407806
Sun S et al. Trichostatin A targets the mitochondrial respiratory chain, increasing mitochondrial reactive oxygen species production to trigger apoptosis in human breast cancer cells. 2014 PLoS ONE pmid:24626188
Kim HR et al. Aberrant Expression of TIMP-2 and PBEF Genes in the Placentae of Cloned Mice Due to Epigenetic Reprogramming Error. 2016 PLoS ONE pmid:27855185
Morinobu A et al. Expression and Functions of Immediate Early Response Gene X-1 (IEX-1) in Rheumatoid Arthritis Synovial Fibroblasts. 2016 PLoS ONE pmid:27736946
Tian Y et al. Ubiquitin B in cervical cancer: critical for the maintenance of cancer stem-like cell characters. 2013 PLoS ONE pmid:24367661
Zhang YW et al. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation. 2012 PLoS ONE pmid:22701735
Tong Y et al. PTTG1 attenuates drug-induced cellular senescence. 2011 PLoS ONE pmid:21858218
Hu Y et al. Trichostatin A selectively suppresses the cold-induced transcription of the ZmDREB1 gene in maize. 2011 PLoS ONE pmid:21811564
Camolotto SA et al. PSG gene expression is up-regulated by lysine acetylation involving histone and nonhistone proteins. 2013 PLoS ONE pmid:23418492
Chachadi VB et al. Prostatic cell-specific regulation of the synthesis of MUC1-associated sialyl Lewis a. 2013 PLoS ONE pmid:23451223
Kuan CS et al. Sp1 and Sp3 Are the Transcription Activators of Human ek1 Promoter in TSA-Treated Human Colon Carcinoma Cells. 2016 PLoS ONE pmid:26807725
Zhang P et al. Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling. 2015 PLoS ONE pmid:26287365
Ignatius MS et al. Distinct functional and temporal requirements for zebrafish Hdac1 during neural crest-derived craniofacial and peripheral neuron development. 2013 PLoS ONE pmid:23667588
O'Leary DA et al. Identification of small molecule and genetic modulators of AON-induced dystrophin exon skipping by high-throughput screening. 2009 PLoS ONE pmid:20020055
Huan Y et al. Epigenetic Modification Agents Improve Gene-Specific Methylation Reprogramming in Porcine Cloned Embryos. 2015 PLoS ONE pmid:26068219
Nunes MJ et al. Histone deacetylase inhibition decreases cholesterol levels in neuronal cells by modulating key genes in cholesterol synthesis, uptake and efflux. 2013 PLoS ONE pmid:23326422
Chan ST et al. Quercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivo. 2013 PLoS ONE pmid:23342112
Terhune SS et al. Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA. 2010 PLoS Pathog. pmid:20585571
Amor DJ et al. Human centromere repositioning "in progress". 2004 Proc. Natl. Acad. Sci. U.S.A. pmid:15084747
Dar RD et al. Transcriptional burst frequency and burst size are equally modulated across the human genome. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:23064634
Condon JC et al. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12886011
Mishra N et al. Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11226290
Porter NJ et al. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors. 2017 Proc. Natl. Acad. Sci. U.S.A. pmid:29203661
Thompson EM et al. Real time imaging of transcriptional activity in live mouse preimplantation embryos using a secreted luciferase. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7877974
Jin S et al. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10841572
Claassen GF and Hann SR A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10920185
Duffy S et al. Overexpression screens identify conserved dosage chromosome instability genes in yeast and human cancer. 2016 Proc. Natl. Acad. Sci. U.S.A. pmid:27551064
Jenster G et al. Steroid receptor induction of gene transcription: a two-step model. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9223281
Bartsch J et al. Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure. 1996 Proc. Natl. Acad. Sci. U.S.A. pmid:8855250
Kenneth NS et al. TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:17848523
Richon VM et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9501205
Ito K et al. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12070353
Condreay JP et al. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:9874783
Selker EU Trichostatin A causes selective loss of DNA methylation in Neurospora. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9689097
Saito A et al. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10200307
Tavera-Mendoza LE et al. Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:18550844
Liu Z et al. Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10449719
Monte M et al. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16847267
Liberatore RA et al. NF-kappaB activity is constitutively elevated in c-Abl null fibroblasts. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19805123
Sasaki K et al. Real-time imaging of histone H4 hyperacetylation in living cells. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19805290
Gibbs A et al. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19805354